12 November 2018
The Stofwisselkracht Foundation raises funds for research into metabolic diseases in a sporting and original way.
Walinka van Tol, Federica Conte and Mohammad Alsady, theme Disorders of movement, received two Stofwisselkracht Foundation grants of 46.000 euro for research into glycosylation related neuromuscular diseases.
More information about the Stofwisselkracht Foundation (only in Dutch): link.
Mohammad Alsady (l) Walinka van Tol (m) Federica Conte (r)
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Five million euro’s for joint research on rare movement disorders
29 March 2022 A Dutch consortium will receive almost 5 million euro’s from NWO to jointly start an ambitious project, called CureQ, on various rare and genetic brain disorders that lead to abnormal movements. Bart van de Warrenburg was one of the main applicants of this ‘Nationale Wetenschaps Agenda (NWA)’ grant. read more
Brain connectivity as biomarker for Parkinson's disease
24 February 2022 Changes in the dopaminergic system have been implicated in various neurological and psychiatric conditions including Parkinson’s disease. The current study is the first to enable the fMRI-based study of dopamine-specific projections in the human brain, thereby providing improved diagnostics. read more
Development of RNA therapy for rare movement disorder SCA7 Brain Foundation grant for Radboudumc and LUMC
3 February 2022 Neurologist Bart van de Warrenburg, together with Willeke van Roon-Mom and Annemieke Aartsma-Rus (both LUMC/Dutch Center for RNA Therapeutics), has been awarded 400,000 euros by the Dutch Brain Foundation to develop a genetic therapy for the rare hereditary movement disorder SCA7. read more
Aerobe exercise has a positive effect on brain function in Parkinson's disease patients
18 January 2022 Radboudumc researchers have shown that the brain function of patients with Parkinson's disease improved with regular exercise, which seems to strengthen the connections between different brain areas, while inhibiting brain shrinkage. read more
New genetic defect links cell biology and protein glycosylation
10 November 2021 Peter Linders, Dirk Lefeber and Geert van den Bogaart together with international colleagues have recently reported on novel cell biological insights, by identifying a genetic disorder in syntaxin-5 which allowed to unravel a new mechanism regulating intracellular transportation. read more